Market Capitalization Analysis of International Flavors & Fragrances
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: NASDAQ.COM
- Market Cap Comparison: International Flavors & Fragrances (IFF) has a market cap of $19.42 billion, compared to Lennar's $18.66 billion, indicating IFF's relative strength in the market, which may attract more large investors.
- Investor Misconceptions: Many beginners mistakenly believe that a higher stock price indicates greater value, but market capitalization provides a more accurate comparison of company value, highlighting the importance of understanding market cap.
- Market Positioning Impact: IFF's market cap makes it more attractive to large-cap investment funds, particularly those focused on companies valued over $10 billion, which could influence its stock liquidity and investor interest.
- Stock Performance: As of Thursday's close, IFF's stock rose approximately 1.7%, while LEN increased by about 3.8%, reflecting differing market sentiments towards the two companies, which may affect future capital inflows.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IFF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IFF
Wall Street analysts forecast IFF stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 76.050
Low
68.00
Averages
80.66
High
89.00
Current: 76.050
Low
68.00
Averages
80.66
High
89.00
About IFF
International Flavors & Fragrances Inc. is a creator and manufacturer of products for application in food, beverage, health and biosciences, scent and complementary adjacent products. Its segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IFF Celebrates 10th Anniversary of Scent Design Program with ISIPCA
- Educational Achievement: Since its launch in 2016, the IFF ISIPCA Scent Design and Creation master's program has trained over 180 professionals from 40 countries, with 130 graduates achieving a 100% job placement rate, highlighting the program's significant impact in the industry.
- Diversity and Innovation: By selecting candidates based on olfactory ability, academic strength, and individual talent, the program fosters diversity in fragrance creation, cultivating talent that combines creativity and technical expertise to meet the evolving demands of the industry.
- Industry Integration: Graduates have found career opportunities across the fragrance ecosystem, including roles at IFF and in fast-moving consumer goods companies, demonstrating the program's crucial role in driving innovation and talent development in the fragrance sector.
- Future Outlook: The 10th anniversary milestone of the IFF ISIPCA program reflects IFF's commitment to investing in the future of fragrance, aiming to drive sustained innovation through education and knowledge transfer, enhancing olfactory experiences for customers and consumers.
See More
Market Capitalization Analysis of International Flavors & Fragrances
- Market Cap Comparison: International Flavors & Fragrances (IFF) has a market cap of $19.42 billion, compared to Lennar's $18.66 billion, indicating IFF's relative strength in the market, which may attract more large investors.
- Investor Misconceptions: Many beginners mistakenly believe that a higher stock price indicates greater value, but market capitalization provides a more accurate comparison of company value, highlighting the importance of understanding market cap.
- Market Positioning Impact: IFF's market cap makes it more attractive to large-cap investment funds, particularly those focused on companies valued over $10 billion, which could influence its stock liquidity and investor interest.
- Stock Performance: As of Thursday's close, IFF's stock rose approximately 1.7%, while LEN increased by about 3.8%, reflecting differing market sentiments towards the two companies, which may affect future capital inflows.
See More
Key Wall Street Rating Changes Overview
- Toll Brothers Upgrade: KBW upgraded Toll Brothers from market perform to market outperform, reflecting resilient luxury demand and improved fundamentals, which is expected to drive growth in the high-end real estate market.
- Park Aerospace Initiation: Citizens initiated coverage on Park Aerospace with a market outperform rating and a $42 price target, citing significant growth opportunities in aerospace materials, particularly in key commercial aviation engine programs.
- Apple Rating Reaffirmed: Morgan Stanley raised its price target on Apple from $330 to $360, noting that WWDC 2026 demonstrated clear progress on Apple's AI roadmap, although monetization will be a long-term endeavor.
- FuelCell Upgrade to Buy: Canaccord upgraded FuelCell from hold to buy, highlighting that the company has deployed nearly one gigawatt of energy blocks globally over the past two decades, showcasing its technology's viability and market potential.
See More
Director Paul J. Fribourg Acquires 273,500 Shares of IFF
- Director's Share Purchase: Paul J. Fribourg, a director at International Flavors & Fragrances, purchased 273,500 shares at $74.29 each for a total of $20.32 million on Monday, indicating strong confidence in the company's future, which may enhance market trust in IFF.
- Stock Price Increase: On Wednesday, IFF's stock rose approximately 2.5%, reflecting positive market reaction to Fribourg's purchase, which could attract more investor interest and further drive up the stock price.
- CEO's Investment in Aurinia: CEO Kevin Tang bought 814,606 shares of Aurinia Pharmaceuticals at $15.29 each for a total of $12.46 million on Tuesday, demonstrating optimism about Aurinia's future potential, which may boost market confidence in the company.
- AUPH Stock Performance: Aurinia Pharmaceuticals saw a 3.6% increase on Wednesday, with Tang's purchase contributing to a 4.6% rise at the day's peak, indicating optimistic market expectations for its future performance and potentially attracting more investor attention.
See More
IFF Sells Food Ingredients Business for $4.3B
- Significant Transaction: IFF has entered into an agreement to sell its food ingredients business to CVC Capital Partners for approximately $4.3 billion, reflecting a robust enterprise value-to-EBITDA multiple of about 10x, indicating strong market interest and valuation recognition for the business.
- Equity Retention for Collaboration: By retaining a 10% minority equity interest valued at around $200 million, IFF ensures ongoing collaboration with the food ingredients business, allowing both IFF and its shareholders to participate in future value creation, thereby enhancing strategic flexibility.
- Clear Use of Proceeds: IFF expects to receive approximately $3.8 billion in net cash proceeds at closing, which will be directed towards debt reduction, targeted share repurchases, and high-return opportunities within its core portfolio, optimizing capital structure and enhancing shareholder value.
- Accelerated Strategic Transformation: This transaction is viewed as a crucial milestone in IFF's portfolio optimization strategy, with CEO Erik Fyrwald stating that by simplifying the business portfolio, IFF will accelerate innovation, drive R&D investment, and more effectively integrate biotechnology and natural capabilities to address long-term trends in health and sustainability.
See More
IFF Sells Food Ingredients Business for $4.3 Billion
- Transaction Value: International Flavors & Fragrances Inc. (IFF) has signed a deal to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, with the transaction expected to close by the end of Q2 2027, marking a significant milestone in the company's portfolio optimization strategy.
- Cash Proceeds: IFF anticipates receiving around $3.8 billion in net cash proceeds from the transaction, which will be utilized to repay debt, fund share repurchases, and reinvest in high-return growth opportunities within its core portfolio, thereby enhancing financial flexibility.
- Earnings Impact: Although the sale is expected to dilute adjusted earnings per share in the first 12 months post-close, IFF plans to improve profitability through capital deployment and addressing stranded overhead costs, demonstrating confidence in future growth.
- Annual Guidance: IFF has reaffirmed its annual guidance for fiscal 2026, expecting adjusted operating EBITDA between $2.05 billion and $2.15 billion, with sales projected between $10.5 billion and $10.8 billion, indicating a stable growth outlook for its core business.
See More
IFF Celebrates 10th Anniversary of Scent Design Program with ISIPCA
- Educational Achievement: Since its launch in 2016, the IFF ISIPCA Scent Design and Creation master's program has trained over 180 professionals from 40 countries, with 130 graduates achieving a 100% job placement rate, highlighting the program's significant impact in the industry.
- Diversity and Innovation: By selecting candidates based on olfactory ability, academic strength, and individual talent, the program fosters diversity in fragrance creation, cultivating talent that combines creativity and technical expertise to meet the evolving demands of the industry.
- Industry Integration: Graduates have found career opportunities across the fragrance ecosystem, including roles at IFF and in fast-moving consumer goods companies, demonstrating the program's crucial role in driving innovation and talent development in the fragrance sector.
- Future Outlook: The 10th anniversary milestone of the IFF ISIPCA program reflects IFF's commitment to investing in the future of fragrance, aiming to drive sustained innovation through education and knowledge transfer, enhancing olfactory experiences for customers and consumers.
See More
Market Capitalization Analysis of International Flavors & Fragrances
- Market Cap Comparison: International Flavors & Fragrances (IFF) has a market cap of $19.42 billion, compared to Lennar's $18.66 billion, indicating IFF's relative strength in the market, which may attract more large investors.
- Investor Misconceptions: Many beginners mistakenly believe that a higher stock price indicates greater value, but market capitalization provides a more accurate comparison of company value, highlighting the importance of understanding market cap.
- Market Positioning Impact: IFF's market cap makes it more attractive to large-cap investment funds, particularly those focused on companies valued over $10 billion, which could influence its stock liquidity and investor interest.
- Stock Performance: As of Thursday's close, IFF's stock rose approximately 1.7%, while LEN increased by about 3.8%, reflecting differing market sentiments towards the two companies, which may affect future capital inflows.
See More
Key Wall Street Rating Changes Overview
- Toll Brothers Upgrade: KBW upgraded Toll Brothers from market perform to market outperform, reflecting resilient luxury demand and improved fundamentals, which is expected to drive growth in the high-end real estate market.
- Park Aerospace Initiation: Citizens initiated coverage on Park Aerospace with a market outperform rating and a $42 price target, citing significant growth opportunities in aerospace materials, particularly in key commercial aviation engine programs.
- Apple Rating Reaffirmed: Morgan Stanley raised its price target on Apple from $330 to $360, noting that WWDC 2026 demonstrated clear progress on Apple's AI roadmap, although monetization will be a long-term endeavor.
- FuelCell Upgrade to Buy: Canaccord upgraded FuelCell from hold to buy, highlighting that the company has deployed nearly one gigawatt of energy blocks globally over the past two decades, showcasing its technology's viability and market potential.
See More
Director Paul J. Fribourg Acquires 273,500 Shares of IFF
- Director's Share Purchase: Paul J. Fribourg, a director at International Flavors & Fragrances, purchased 273,500 shares at $74.29 each for a total of $20.32 million on Monday, indicating strong confidence in the company's future, which may enhance market trust in IFF.
- Stock Price Increase: On Wednesday, IFF's stock rose approximately 2.5%, reflecting positive market reaction to Fribourg's purchase, which could attract more investor interest and further drive up the stock price.
- CEO's Investment in Aurinia: CEO Kevin Tang bought 814,606 shares of Aurinia Pharmaceuticals at $15.29 each for a total of $12.46 million on Tuesday, demonstrating optimism about Aurinia's future potential, which may boost market confidence in the company.
- AUPH Stock Performance: Aurinia Pharmaceuticals saw a 3.6% increase on Wednesday, with Tang's purchase contributing to a 4.6% rise at the day's peak, indicating optimistic market expectations for its future performance and potentially attracting more investor attention.
See More
IFF Sells Food Ingredients Business for $4.3B
- Significant Transaction: IFF has entered into an agreement to sell its food ingredients business to CVC Capital Partners for approximately $4.3 billion, reflecting a robust enterprise value-to-EBITDA multiple of about 10x, indicating strong market interest and valuation recognition for the business.
- Equity Retention for Collaboration: By retaining a 10% minority equity interest valued at around $200 million, IFF ensures ongoing collaboration with the food ingredients business, allowing both IFF and its shareholders to participate in future value creation, thereby enhancing strategic flexibility.
- Clear Use of Proceeds: IFF expects to receive approximately $3.8 billion in net cash proceeds at closing, which will be directed towards debt reduction, targeted share repurchases, and high-return opportunities within its core portfolio, optimizing capital structure and enhancing shareholder value.
- Accelerated Strategic Transformation: This transaction is viewed as a crucial milestone in IFF's portfolio optimization strategy, with CEO Erik Fyrwald stating that by simplifying the business portfolio, IFF will accelerate innovation, drive R&D investment, and more effectively integrate biotechnology and natural capabilities to address long-term trends in health and sustainability.
See More
IFF Sells Food Ingredients Business for $4.3 Billion
- Transaction Value: International Flavors & Fragrances Inc. (IFF) has signed a deal to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, with the transaction expected to close by the end of Q2 2027, marking a significant milestone in the company's portfolio optimization strategy.
- Cash Proceeds: IFF anticipates receiving around $3.8 billion in net cash proceeds from the transaction, which will be utilized to repay debt, fund share repurchases, and reinvest in high-return growth opportunities within its core portfolio, thereby enhancing financial flexibility.
- Earnings Impact: Although the sale is expected to dilute adjusted earnings per share in the first 12 months post-close, IFF plans to improve profitability through capital deployment and addressing stranded overhead costs, demonstrating confidence in future growth.
- Annual Guidance: IFF has reaffirmed its annual guidance for fiscal 2026, expecting adjusted operating EBITDA between $2.05 billion and $2.15 billion, with sales projected between $10.5 billion and $10.8 billion, indicating a stable growth outlook for its core business.
See More
